| Version |
2.5 |
| Creation Date |
2006-05-22 15:17:32 |
| Update Date |
2009-05-05 20:59:02 |
| Accession Number |
HMDB02027 |
| Secondary Accession Numbers |
Not Available |
| Common Name |
8-Dehydrocholesterol |
| Description |
8-Dehydrocholesterol (8-DHC) elevated concentration is one of the diagnostic biochemical hallmarks of classical Smith-Lemli-Opitz syndrome (SLOS) . Plasma 8-DHC could be only marginally elevated. (PMID: 16435228)
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive condition caused by a defect in cholesterol synthesis (caused by a deficit of 3beta-hydroxysterol-Delta7 reductase). Affected children often have malformations and mental retardation. Autistic behaviors also are evident. In children, the baseline cholesterol, 8-DHC levels, and cholesterol levels following supplementation does not correlate with the presence or severity of autistic symptoms. (PMID: 16761297)
Accumulation of 8-dehydrocholesterol in Amniotic fluid is diagnostic for SLOS. (PMID 16231320) |
| Synonyms |
- 3b-Cholesta-5,8-dien-3-ol
- 8-Dehydrocholesterol
|
| Chemical IUPAC Name |
(3S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
| Chemical Formula |
C27H44O |
| Chemical Structure |
 |
| Chemical Taxonomy |
| Kingdom |
|
| Super Class |
- Cholesterols and derivatives
|
| Class |
- Steroids and Steroid Derivatives
|
| Sub Class |
|
| Family |
|
| Species |
|
| Biofunction |
- Hormones, Membrane component
|
| Application |
| — |
| Source |
|
|
| Average Molecular Weight |
384.638 |
| Monoisotopic Molecular Weight |
384.339203 |
| Isomeric SMILES |
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)CC1=CC3 |
| Canonical SMILES |
CC(C)CCCC(C)C1CCC2C3=C(CCC12C)C1(C)CCC(O)CC1=CC3 |
| KEGG Compound ID |
Not Available |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB02027  |
| Metagene Link |
HMDB02027  |
| METLIN ID |
Not Available |
| PubChem Compound |
129846  |
| PubChem Substance |
10242450  |
| ChEBI ID |
Not Available |
| CAS Registry Number |
70741-38-7 |
| InChI Identifier |
InChI=1/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21,23-24,28H,6-8,10-17H2,1-5H3/t19-,21+,23-,24+,26+,27-/m1/s1 |
| Synthesis Reference |
Not Available |
| Melting Point (Experimental) |
Not Available |
| Experimental Water Solubility |
Not Available
Source: PhysProp
|
| Predicted Water Solubility |
9.14e-04 mg/mL [Predicted by ALOGPS]
Calculated using ALOGPS
|
| Physiological Charge |
0 |
| State |
Solid |
| Experimental LogP/Hydrophobicity |
Not Available
Source: PhysProp
|
| Predicted LogP/Hydrophobicity |
7.4 [Predicted by PubChem via XLOGP]; 6.91 [Predicted by ALOGPS]
Calculated using ALOGPS
|
| Material Safety Data Sheet (MSDS) |
Not Available |
| MOL File |
Show |
| SDF File |
Show |
| PDB File |
Show |
| 2D Structure |
|
| 3D Structure |
|
| Experimental PDB ID |
Not Available |
| Experimental 1H NMR Spectrum |
Not Available |
| Experimental 13C NMR Spectrum |
Not Available |
| Experimental 13C HSQC Spectrum |
Not Available |
| Predicted 1H NMR Spectrum |
Show Image Show Peaklist
|
| Predicted 13C NMR Spectrum |
Show Image Show Peaklist
|
| Mass Spectrum |
Not Available |
| Simplified TOCSY Spectrum |
Not Available |
| BMRB Spectrum |
Not Available |
| Cellular Location |
Not Available |
| Biofluid Location |
- Blood
- Cerebrospinal Fluid
|
| Tissue Location |
Not Available |
| Concentrations (Normal) |
| Biofluid |
Blood |
| Value |
0.65 (0.0-1.3) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Honda M, Tint GS, Honda A, Salen G, Shefer S, Batta AK, Matsuzaki Y, Tanaka N: Regulation of cholesterol biosynthetic pathway in patients with the Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 2000 Jul;23(5):464-74. [PubMed
]
|
|
| Concentrations (Abnormal) |
| Biofluid |
Blood |
| Value |
312.0 +/- 52.0 uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Condition |
Smith-Lemli-Opitz syndrome |
| Comments |
Not Available |
| References |
- Honda M, Tint GS, Honda A, Salen G, Shefer S, Batta AK, Matsuzaki Y, Tanaka N: Regulation of cholesterol biosynthetic pathway in patients with the Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 2000 Jul;23(5):464-74. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0.3 +/- 0.1 (0.2 - 0.5) uM |
| Age |
Infant:0-1 yr old |
| Sex |
N/A |
| Condition |
Smith-Lemli-Opitz syndrome |
| Comments |
Not Available |
| References |
- van Rooij A, Nijenhuis AA, Wijburg FA, Schutgens RB: Highly increased CSF concentrations of cholesterol precursors in Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 1997 Aug;20(4):578-80. [PubMed
]
|
|
| Associated Disorders |
| Condition |
References |
| Smith-Lemli-Opitz syndrome |
|
|
| OMIM ID |
- 270400
(Smith-Lemli-Opitz syndrome)
|
| Pathways |
|
| General References |
- van Rooij A, Nijenhuis AA, Wijburg FA, Schutgens RB: Highly increased CSF concentrations of cholesterol precursors in Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 1997 Aug;20(4):578-80. [PubMed
]
|